Literature DB >> 14990754

A reality test: How well do we understand psychosis in Parkinson's disease?

M Saleem Ismail1, Irene Hegeman Richard.   

Abstract

Psychosis in Parkinson's disease (PD) is a major source of distress to patients and caregivers. Although the advent of atypical antipsychotic agents has, to some extent, resolved a clinical dilemma by preserving motor function while treating psychosis, our understanding of psychosis in PD remains in a nascent state. In this article the authors address several issues relating to psychosis in PD including the following: 1) prevalence, 2) possible etiologies and risk factors and 3) treatment. They also identify limitations in our understanding of this complex phenomenon and conclude that, despite availability of reasonable treatments for psychosis in PD, the search for a better understanding of the phenomenon must continue.

Entities:  

Mesh:

Year:  2004        PMID: 14990754     DOI: 10.1176/jnp.16.1.8

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  5 in total

Review 1.  Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.

Authors:  C Mehler-Wex; P Riederer; M Gerlach
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

2.  Factors associated with drug-induced visual hallucinations in Parkinson's disease.

Authors:  Spiridon Papapetropoulos; Andreas A Argyriou; John Ellul
Journal:  J Neurol       Date:  2005-04-18       Impact factor: 4.849

3.  Depression in veterans with Parkinson's disease: frequency, co-morbidity, and healthcare utilization.

Authors:  Peijun Chen; Helen C Kales; Daniel Weintraub; Frederic C Blow; Lan Jiang; Rosalinda V Ignacio; Alan M Mellow
Journal:  Int J Geriatr Psychiatry       Date:  2007-06       Impact factor: 3.485

4.  Efficacy and safety of rotigotine in elderly patients with Parkinson's disease in comparison with the non-elderly: a post hoc analysis of randomized, double-blind, placebo-controlled trials.

Authors:  Masahiro Nomoto; Hirotaka Iwaki; Hiroyuki Kondo; Masaya Sakurai
Journal:  J Neurol       Date:  2017-11-21       Impact factor: 4.849

5.  Management of Psychotic Symptoms in a Patient With Parkinson's Disease Maintained on Levodopa-Carbidopa Intestinal Gel by Paliperidone Long-Acting Injection: A Case Report.

Authors:  Abdulkarim O Alanazi; Abdulaziz A Boqaeid; Mohammed A Alnuwaysir
Journal:  Cureus       Date:  2022-01-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.